CollPlant Biotechnologies: Leading 3D Bioprinting for Regenerative Medicine
CollPlant Biotechnologies, Nasdaq‑listed and focused on 3D bioprinting, pioneers regenerative medicine for orthobiologics and advanced wound care, promising transformative healthcare solutions.
- COLLPLANT BIOTECHNOLOGIES LT
- Health Care
- Pharmaceuticals, Biotechnology & Life Sciences
- AI generated
2 minutes to read